Distribution of adenosine receptors in the postmortem human brain: An extended autoradiographic study

Synapse

Volumn 27, Issue 4, 1997, Pages 322-335

  Svenningsson, Per ^a   Hall, Håkan ^b   Sedvall, Göran ^b   Fredholm, Bertil B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adenosine analogues; Basal ganglia; Cerebral cortex; Hippocampus; Human; Xanthines

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; RADIOLIGAND; TRITIUM;

ADULT; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CADAVER; CHOLINERGIC TRANSMISSION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RECEPTOR BINDING; TISSUE DISTRIBUTION;

AUTORADIOGRAPHY; BINDING, COMPETITIVE; BRAIN; FEMALE; FRONTAL LOBE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PUTAMEN; RADIOLIGAND ASSAY; RECEPTORS, PURINERGIC P1; TEMPORAL LOBE;

EID: 0030716172     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199712)27:4<322::AID-SYN6>3.0.CO;2-E     Document Type: Article

References (67)

1. 1 adenosine receptors in human temporal lobe epilepsy: a quantitative autoradiographic study. Neurosci. Lett., 163:11-14.
2. Aquilonius, S.-M., and Eckernäs, S.-Å. (1980) In: A Colour Atlas of the Human Brain. Esselte Studium, Solna.
3. 3H]-NECA in rat striatal membranes. Mol. Pharmacol., 29:331-346.
4. 1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn Schmiedebergs Arch. Pharmacol., 335:59-63.
5. 1 receptors. J. Pharmacol. Exp. Ther., 273:637-642.
6. 50) of an enzymatic reaction. Biochem. Pharmacol., 22:3099-3108.
7. Cortés, R., Probst, A., and Palacios, J.M. (1987) Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: forebrain. Neuroscience, 20:65-107.
8. 2a receptors in the rat hippocampus. Brain Res., 649:208-216.
9. 2A receptors. Naunyn Schmiedebergs Arch. Pharmacol., 353:261-271.
10. Daly, J.W. (1993) Mechanism of action of caffeine. In: Caffeine, Coffee, and Health. S. Garattini, ed. Lippincott-Raven, New York, pp. 97-150.
11. 1-receptors in rat brain: autoradiographic evidence for increased receptor number and altered coupling to G-proteins. Brain Res., 507:195-199.
12. 1-receptors in rat brain, as revealed by autoradiography. Neuroscience, 34:759-769.
13. 1 receptors in human brain: characterization and autoradiographic visualization. Neurosci. Lett., 65:127-132.
14. 1-receptors and 5′-nucleotidase in the brain of some commonly used experimental animals. Neuroscience, 22:813-826.
15. 1 receptors in the human brain: a quantitative autoradiographic study. Neuroscience, 22:827-839.
16. 2 receptors induces catalepsy. Neurosci. Lett., 130:162-164.
17. 2 receptors in rat striatal membranes. Proc. Natl. Acad. Sci. U.S.A., 88:7238-7241.
18. Ferré, S., O'Connor, W.T., Fuxe, K., and Ungerstedt, U. (1993) The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J. Neurosci., 13:5402-5406.
19. 1 receptors. Neuroreport, 6:73-76.
20. 1 receptor-mediated mechanisms. Eur. J. Neurosci., 8:1545-1533.
21. 2 dopamine receptors in rat striatum. Brain Res. Mol. Brain Res., 14:186-195.
22. Fredholm, B.B. (1980) Are methylxanthine effects due to antagonism of endogenous adenosine? Trends Pharmacol. Sci., 1:129-132.
23. Fredholm, B.B. (1995) Adenosine, adenosine receptors and the actions of caffeine. Pharmacol. Toxicol., 76:93-101.
24. Fredholm, B.B., and Dunwiddie, T.V. (1988) How does adenosine inhibit transmitter release? Trends Pharmacol. Sci., 9:130-134.
25. Fredholm, B.B., Fuxe, K., and Agnati, L. (1976) Effect of some phosphodiesterase inhibitors on central dopamine mechanisms. Eur. J. Pharmacol., 38:31-38.
26. Fredholm, B.B., Abbracchio, M.P., Burnstock, G., Daly, J.W., Harden, T.K., Jacobson, K.A., Leff, P., and Williams, M. (1994) Nomenclature and classification of purinoceptors. Pharmacol. Rev., 46:143-156.
27. 2 receptor. Brain Res. Mol. Brain Res., 15:62-66.
28. Geary II, W.A., and Wooten, G.F. (1983) Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain. J. Pharmacol. Exp. Ther., 225:234-240.
29. 3H]-cyclohexyladenosine. J. Neurosci., 2:1230-1241.
30. 2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology, 11:245-256.
31. 2-dopamine receptor binding in the post-mortem human brain: an autoradiographic study. Eur. Neuropsychopharmacol., 5:19-25.
32. 125I]epidepride. Synapse, 23:115-123
33. 2 selective adenosine receptor agonist with preferential hypotensive activity. J. Pharmacol. Exp. Ther., 251:47-55.
34. 2a receptors. Drug Dev. Res., 28:226-231.
35. James, S., Xuereb, J.H., Askalan, R., and Richardson, P.J. (1992) Adenosine receptors in post-mortem human brain. Br. J. Pharmacol., 105:238-244.
36. 3H]CGS 21680. Eur. J. Pharmacol., 168:243-246.
37. 2-adenosine receptors using radioligand binding and photoaffinity labeling. J. Recept. Res., 12:149-169.
38. 2 receptor stimulation on electrically evoked dopamine and acetylcholine release from rat striatal slices. J. Pharmacol. Exp. Ther., 267:801-808.
39. 2 adenosine receptor binding and on mRNA levels. Naunyn Schmiedebergs Arch. Pharmacol., 347:407-414.
40. 3H]CGS 21680 to rat cortex differs from its binding to rat striatum. Eur. J. Pharmacol. Mol. Pharmacol. Sect., 247:103-110.
41. John, D., and Fox, I.H. (1985) Characteristics of high-affinity and low-affinity adenosine binding sites in human cerebral cortex. J. Lab. Clin. Med., 106:401-407.
42. 3H]-CGS 21680 binding sites in the rat striatum and cortex. Br. J. Pharmacol., 114:537-543.
43. 2A receptors. Pharmacol. Toxicol., 76(Suppl. II):P1.26.
44. 1 adenosine receptor. Biochem. Biophys. Res. Commun., 187:919-926.
45. 3H]-CGS 21680 in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol., 354:539-541.
46. 125I]iodophenyl)ethylamino]adenosine. Mol. Pharmacol., 47:307-313.
47. 1 adenosine receptor from rat brain. Mol. Pharmacol., 40:1-7.
48. 2 receptors: selective localization in the human basal ganglia and alterations with disease. Neuroscience, 42:697-706.
49. 2+ ion. Biochem. Biophys. Acta, 1220:76-84.
50. Mesulam, M.-M. (1995) Structure and function of cholinergic pathways in the cerebral cortex, limbic system, basal ganglia, and thalamus of the human brain. In: Psychopharmacology: The Fourth Generation of Progress. F.E. Bloom and D.J. Kupfer, eds. Lippincott-Raven, New York, pp. 135-153.
51. Miller, R.A., and Burack, E. (1982) In: Atlas of the Central Nervous System in Man, 3rd Ed. Williams & Williams, Baltimore.
52. 3H]-CGS 21680 as a ligand. Naunyn Schmiedebergs Arch. Pharmacol., 342:85-89.
53. 2 receptors: a quantitative autoradiographical study. Mol. Neuropharmacol., 1:179-186.
54. 1 receptors: a complicating factor in quantitative autoradiography. J. Neurochem., 58:941-950.
55. 2b receptors from human brain. Biochem. Biophys. Res. Commun., 187:86-93.
56. 2 dopamine-dependent activation of Fos in the striatopallidal pathway. Neuroscience, 68:721-728.
57. Rainnie, D.G., Grunze, H.C.R., McCarley, R.W., and Greene, R.W. (1994) Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal. Science, 263:689-692.
58. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A., 90:10365-10369.
59. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J. Neurochem., 57:1062-1067.
60. 2-adenosine receptor subtype. Mol. Endocrinol., 6:384-393.
61. 2A receptors in rat brain. J. Pharmcol. Exp. Ther., 280:1094-1101.
62. Svenningsson, P., Nomikos, G.G., and Fredholm, B.B. (1995) Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. J. Neurosci., 15:7612-7624.
63. 3H]CGS 21680 to human and rat brain: evidence for multiple affinity sites. J. Neurochem., 55:1763-1771.
64. 1 adenosine receptors in rat brain with [3H]8-cyclopentyl-1,3-dipropylxanthine. J. Neurochem., 54:1344-1353.
65. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A., 89:7432-7436.
66. Zocchi, C., Ongini, E., Baraldi, P.G., and Dionisotti, S. (1995) SCH 58261, a new potent and selective adenosine receptor antagonist. Br. J. Pharmacol., 114[Proc. Suppl.]:299P.
67. 2A adenosine receptor antagonist. J. Pharmacol. Exp. Ther., 276:398-404.